Can I Take Turmeric or Curcumin with Lisinopril?

Why This Combination Raises Questions

Turmeric supplements rank among the top-selling herbal products in the United States, with retail sales exceeding $148 million in 2023 according to the American Botanical Council's HerbalGram market report. Lisinopril is the third most-prescribed medication in the country, with over 88 million dispensed prescriptions annually per IQVIA/FDA data. The statistical overlap between users of both is substantial.

Where the Concern Originates

Curcumin, the principal curcuminoid in turmeric, has documented anti-inflammatory and mild antiplatelet activity. Lisinopril lowers blood pressure by blocking angiotensin-converting enzyme (ACE). When a supplement that can reduce blood pressure on its own meets a prescription drug designed to do the same thing, the theoretical risk of excessive hypotension exists. A 2019 meta-analysis of 11 randomized controlled trials (N=734) published in Pharmacological Research found that curcumin supplementation reduced systolic blood pressure by a mean of 1.3 mmHg, though the reduction reached 3 to 4 mmHg in trials lasting 12 weeks or longer 1.

Why Patients Often Combine Them

Many patients with hypertension also manage chronic low-grade inflammation, joint pain, or metabolic syndrome. Curcumin's NF-kB inhibition pathway makes it an appealing adjunct. The question is not whether the combination is categorically dangerous. It is whether any precautions make it safer.

Mechanism of the Interaction

The turmeric-lisinopril interaction operates through two distinct channels: a pharmacodynamic overlap on vascular tone and a minor pharmacokinetic effect on drug metabolism. Neither channel alone is alarming, but together they warrant attention in certain patients.

Pharmacodynamic Pathway: Additive Blood-Pressure Lowering

Lisinopril reduces angiotensin II production, which relaxes arterial smooth muscle and decreases aldosterone-driven sodium retention. Curcumin independently promotes endothelial nitric oxide (NO) production, according to a 2017 study in the Journal of Nutritional Biochemistry (N=59 postmenopausal women), which found improved flow-mediated dilation after 8 weeks of 150 mg/day curcumin 2. That NO-mediated vasodilation adds to the ACE-inhibitor effect, meaning the net blood pressure drop may exceed what either agent achieves alone.

For most patients on stable lisinopril doses (10 to 40 mg/day) who add a standard curcumin supplement (500 to 1,000 mg/day), the additive effect is modest. The risk becomes clinically meaningful in patients already prone to orthostatic hypotension: older adults, those on diuretics, or individuals with autonomic neuropathy.

Pharmacokinetic Pathway: CYP Enzyme Inhibition

Curcumin inhibits CYP3A4 and CYP2C9 in vitro, as demonstrated in a frequently cited 2012 study in Drug Metabolism and Disposition 3. Lisinopril, unlike most ACE inhibitors, is not metabolized by the liver. It is excreted unchanged by the kidneys. This means the CYP inhibition concern is largely irrelevant for lisinopril specifically.

The distinction matters. If a patient switched from lisinopril to an ACE inhibitor with hepatic metabolism (such as enalapril or ramipril), the curcumin-CYP interaction would become more significant. For lisinopril users, the pharmacokinetic risk is minimal.

Anticoagulant Overlap

Curcumin inhibits platelet aggregation via thromboxane A2 suppression and COX-2 downregulation. A 2012 study in BMB Reports showed curcumin reduced ADP-induced and arachidonic acid-induced platelet aggregation in healthy volunteers (N=24) at doses of 600 mg/day 4. Lisinopril itself carries no anticoagulant properties. The bleeding concern becomes relevant when patients take lisinopril alongside a separate anticoagulant (warfarin, apixaban, rivaroxaban) and then add curcumin as a third agent.

Risk Stratification: Who Needs to Be Most Careful

Not every patient faces the same risk profile when combining these two agents. A 45-year-old on lisinopril 10 mg with normal renal function and no other medications has a very different risk calculus than a 78-year-old on lisinopril 40 mg, hydrochlorothiazide, and apixaban.

Lower-Risk Patients

Patients under 65, on a single antihypertensive (lisinopril alone), with an eGFR above 60 mL/min/1.73m², taking a standard-dose curcumin supplement (500 mg or less of standardized extract daily), and not on any anticoagulant. These patients can generally combine the two with basic monitoring.

Higher-Risk Patients

Patients over 75, on multiple antihypertensives, with eGFR below 45, on concurrent anticoagulants, or with a history of falls or syncope. These patients should discuss the combination with their prescriber before starting and may need more frequent blood-pressure and renal-function monitoring.

The Piperine Variable

Many curcumin supplements include piperine (black pepper extract) to enhance bioavailability. BioPerine, the most common branded piperine additive, increases curcumin absorption by up to 2,000% according to a 1998 study in Planta Medica 5. Piperine also inhibits CYP3A4 and P-glycoprotein. While this still does not affect lisinopril's renal clearance directly, it can alter the metabolism of co-administered medications. Patients on polypharmacy regimens should flag piperine-containing supplements to their pharmacist.

Dose-Separation and Practical Guidelines

Timing and dosing adjustments can reduce the interaction risk to a clinically acceptable level for most patients.

Separation Window

Take curcumin supplements at least 2 hours apart from lisinopril. This reduces the chance of peak pharmacodynamic overlap. Lisinopril reaches peak plasma concentration (Tmax) at approximately 7 hours after oral dosing, per its FDA prescribing information [6]. Curcumin (without piperine) has a Tmax of 1 to 2 hours. Taking curcumin in the morning and lisinopril at bedtime, or vice versa, provides a practical separation strategy.

Dosing Thresholds

Culinary turmeric (the spice in cooking) delivers roughly 3% curcuminoids by weight. A teaspoon of ground turmeric contains approximately 200 mg of curcuminoids, and at this level, the interaction risk is negligible. Standardized curcumin supplements deliver 500 to 2,000 mg of curcuminoids per dose. The interaction risk scales with dose. Staying at or below 1,000 mg/day of standardized curcumin is reasonable for most lisinopril users.

What to Avoid

Do not take high-dose curcumin (above 1,500 mg/day) without prescriber awareness. Do not combine curcumin with lisinopril and an anticoagulant without explicit clinical sign-off. Do not start both agents simultaneously. If initiating curcumin while on stable lisinopril, add it at the lowest available dose and monitor for 2 weeks.

Monitoring Parameters

Home monitoring is the most practical tool for patients combining these agents. Clinic visits alone miss transient hypotensive episodes that occur between appointments.

Blood-Pressure Monitoring

The American Heart Association recommends home blood-pressure monitoring for all patients on antihypertensives, using a validated upper-arm cuff 7. When adding curcumin to lisinopril, check blood pressure twice daily (morning and evening) for the first 2 weeks. A systolic drop below 100 mmHg, or any symptomatic lightheadedness upon standing, should prompt discontinuation of the supplement and a call to the prescriber.

Renal Function

Lisinopril can raise serum creatinine by 10 to 15% as a known pharmacological effect of ACE inhibition. Curcumin at high doses may have oxalate-related renal effects, though clinical evidence for this is limited. Patients with baseline CKD (eGFR <60) should have a basic metabolic panel checked 4 to 6 weeks after adding curcumin, as recommended by the KDIGO 2024 clinical practice guideline for monitoring ACE-inhibitor therapy [8].

Bleeding Surveillance

No routine lab monitoring is needed for the curcumin-lisinopril pair alone. Patients should watch for unexplained bruising, prolonged bleeding from minor cuts, nosebleeds, or blood in stool. Any of these warrants a prompt prescriber visit. Patients concurrently on warfarin should have INR checked 1 to 2 weeks after adding curcumin.

What the Evidence Actually Shows

Direct clinical trial data on curcumin plus lisinopril specifically does not exist. The safety profile is constructed from parallel lines of evidence.

Animal Data

A 2014 study in European Journal of Pharmacology tested curcumin (100 mg/kg) with captopril (another ACE inhibitor) in spontaneously hypertensive rats and found additive blood-pressure reduction without renal toxicity 9. While animal-to-human extrapolation is imperfect, the result supports the pharmacodynamic mechanism described above.

Human Pharmacology Studies

The 2019 meta-analysis by Hadi et al. In Pharmacological Research (11 RCTs, N=734) confirmed that curcumin modestly reduces systolic blood pressure, with greater effects in longer-duration supplementation and in patients with existing metabolic abnormalities 1. A 2020 systematic review in Complementary Therapies in Medicine (N=1,062 across 16 trials) found no serious adverse events attributable to curcumin at doses up to 2,000 mg/day over 12 weeks, though GI side effects (nausea, diarrhea) occurred in 3 to 8% of participants 10.

Case Reports

The Natural Medicines Comprehensive Database classifies the turmeric-ACE inhibitor interaction as "moderate" based on pharmacological plausibility rather than published adverse-event case reports. No case reports of serious harm from the specific curcumin-lisinopril combination were identified in PubMed through May 2026.

What Clinicians Say

Dr. Tieraona Low Dog, former member of the White House Commission on Complementary and Alternative Medicine Policy, has noted: "Turmeric is one of the safest botanicals available, but patients on antihypertensives should treat it as they would any agent that lowers blood pressure: start low, monitor, and communicate with their care team."

The Endocrine Society's 2023 clinical practice guideline on supplements and cardiometabolic health states: "Clinicians should inquire about herbal supplement use at every hypertension visit, as additive hemodynamic effects are underrecognized" 11.

If You Are Already Taking Both

Many patients discover interaction concerns only after combining the two agents for weeks or months. If you are already taking curcumin with lisinopril and have experienced no symptoms, that is reassuring but does not eliminate the need for monitoring.

Steps to Take Now

Check your blood pressure at home for 5 consecutive days, recording morning and evening readings. Review the curcumin product label for piperine content and total curcuminoid dose. Bring the supplement bottle to your next prescriber visit. If your systolic pressure consistently reads below 110 mmHg or you experience dizziness, reduce the curcumin dose by half and recheck over 1 week.

When to Stop Curcumin

Stop immediately and contact your prescriber if you experience syncope (fainting), unexplained significant bruising, systolic blood pressure below 90 mmHg, or new onset of peripheral edema. These symptoms may indicate an interaction that requires clinical reassessment.

Special Populations

Patients with Diabetes

Lisinopril is frequently prescribed in type 2 diabetes for renal protection. Curcumin has shown modest glucose-lowering effects in a 2019 RCT published in Nutrition Journal (N=80), reducing fasting glucose by 8.9 mg/dL over 12 weeks vs. Placebo 12. Patients on insulin or sulfonylureas who add curcumin alongside lisinopril should monitor for hypoglycemia as well as hypotension.

Patients on Diuretics

Hydrochlorothiazide and chlorthalidone are commonly co-prescribed with lisinopril. The triple combination of a diuretic, ACE inhibitor, and curcumin creates a higher risk of volume depletion and electrolyte disturbance. These patients should have electrolytes (potassium, sodium) checked within 4 weeks of adding curcumin.

Perioperative Patients

Because curcumin has antiplatelet activity, most surgical guidelines recommend discontinuing herbal supplements with anticoagulant properties at least 2 weeks before elective surgery. The American Society of Anesthesiologists' 2023 practice advisory on perioperative herbal medicine supports this recommendation 13.

Patients on lisinopril 40 mg/day who add curcumin 500 mg/day with piperine should have a home blood-pressure log reviewed by their prescriber at the next visit, with the first check occurring within 2 weeks of starting the supplement.